Whistleblower: Purdue Pharma continued deceptive sales practices for OxyContin after 2007
A former sales representative for Purdue Pharma? tells CBS News' Tony Dokoupil that the drug maker continued to engage in deceptive sales practices for its opiate painkiller OxyContin later than the company previously acknowledged. Carol Panara joined Purdue Pharma as a sales representative in 2008. Watch the full report Thursday, June 21 on "CBS This Morning," which airs 7 a.m. to 9 a.m. ET/PT.